Mutation Analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 Patients With MDS or Secondary AML

Leukemia - United Kingdom
doi 10.1038/leu.2010.124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Donor HSCs With a Preexisting ASXL1-mutation Led to the Development of FLT3-ITD Positive AML in the Donor and FLT3-ITD Negative AML in the Recipient After Unrelated Transplant

Bone Marrow Transplantation
TransplantationHematology
2018English

NOX-driven ROS Formation in Cell Transformation of FLT3-ITD-positive AML

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2016English

Association Between Increased Mutation Rates in DNMT3Α and FLT3‑ITD and Poor Prognosis of Patients With Acute Myeloid Leukemia

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Adult Acute Myeloid Leukemia With Trisomy 11 as the Sole Abnormality Is Characterized by the Presence of Five Distinct Gene Mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2016English

Physicians Poster Session: Acute Leukemia and Secondary AML/MDS

Bone Marrow Transplantation
TransplantationHematology
2003English

Identification of FLT3 and NPM1 Mutations in Patients With Acute Myeloid Leukaemia

Asian Pacific Journal of Cancer Prevention
2019English

Dnmt3a Deletion Cooperates With the Flt3/Itd Mutation to Drive Leukemogenesis in a Murine Model

Oncotarget
Oncology
2016English

FLT3-ITD Compared With DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult AML Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

Turkish Journal of Haematology
Hematology
2018English

Glasdegib in Combination With Cytarabine and Daunorubicin in Patients With AML or High-Risk MDS: Phase 2 Study Results

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy